Report: Corporate venture capital is catalyzing groundbreaking biomedical innovation in the United States
By Anne McDonald Pritchett, PhD | October 10, 2018
Venture capital is increasingly becoming the growing force for financing biotech and other startups, fueling medical advances in the U.S. A new report released today from TEConomy, examines the...
Read More
ICYMI: Wall Street Journal highlights dangers of counterfeit medicines entering the United States through drug importation
By Nicole Longo | October 9, 2018
This week, the Wall Street Journal took a closer look at the very real threat drug importation poses, detailing how such schemes expose Americans to dangerous counterfeit medicines. The reporter...
Read More
Coupons allow patients to remain on medicines in spite of high cost sharing and deductibles
By Katie Koziara | October 4, 2018
According to a new report by IQVIA Institute for Human Data Science, more and more patients are asked to pay high cost sharing due to changes in benefit design. Previous analysis has shown that...
Read More
Examining the truth behind clinical trial costs
By John Corea | October 2, 2018
Last week, a study appearing in the Journal of the American Medical Association (JAMA) Internal Medicine, evaluated the costs specifically associated with successful clinical trials for novel...
Read More
Event tomorrow: Leaders convene to discuss solutions to advance value-driven health care
By Katie Koziara | October 2, 2018
Tomorrow, October 3, PhRMA will convene health care leaders for a discussion on how we can move our health care system toward one focused on value rather than volume, ensuring patients can access...
Read More
Safe and effective prescribing: A new and important initiative from the PhRMA Foundation
By Eileen Cannon | September 26, 2018
Safe and effective prescribing is a critically important part of the equation for successful medical treatment in today’s health care system. Yet data from the Association of American Colleges...
Read More
PhRMA comments in response to request for information on competitive bidding program in Medicare Part B
By Nicole Longo | September 25, 2018
Yesterday, the Pharmaceutical Research and Manufacturers of America (PhRMA) submitted comments in response to the recent 2019 Hospital Outpatient Prospective Payment System proposed rule,...
Read More
New report shows more than 300 skin disease medicines in development
By Andrew Powaleny | September 25, 2018
More than 100 million Americans – one third of the U.S. population – suffer from skin conditions.
Read More
Experts agree: the Bipartisan Budget Act changes to Medicare Part D jeopardize the program
By Juliet Johnson | September 24, 2018
The changes made to Part D in the Bipartisan Budget Act (BBA) that passed in February threaten the program’s successful competitive structure. While these changes closed the donut hole a year...
Read More
Five myths about global efforts to combat tuberculosis
By Megan Van Etten | September 20, 2018
On September 26, world leaders will convene in New York for the first-ever United Nations (UN) High-Level Meeting on Ending Tuberculosis (TB). This event could not be more critical – or more...
Read More
Medicare Monday (100)
340B Spotlight (37)
Cost & Consequence (0)
